allosource
-
Sports Medicine
AlloSource Announces First Patients Complete 12-Month Milestone In ProChondrix CR Clinical Study For Cartilage Defects In The Knee
CENTENNIAL, Colo., Nov. 17, 2020 /PRNewswire/ –AlloSource®, one of the largest allograft providers in the U.S., creating innovative cellular and tissue products,…
Read More » -
Biologics
AlloSource® Names Tendon And Ligament Portfolio Under New Brand AlloConnex™
CENTENNIAL, Colo., July 23, 2020 /PRNewswire/ — AlloSource®, one of the largest allograft providers in the U.S., creating innovative cellular and tissue allografts…
Read More » -
Biologics
Research Shows ProChondrix® CR Maintains Consistent, High Cell Viability For Two Years
CENTENNIAL, Colo., Oct. 7, 2019 /PRNewswire/ — AlloSource, an organization dedicated to advancing the science and use of transplantable allogeneic cells and…
Read More » -
Biologics
AlloSource Celebrates 25 Years Of Doing More With Life
CENTENNIAL, Colo., Aug. 9, 2019 /PRNewswire/ — AlloSource®, an organization dedicated to advancing the science and use of transplantable allogeneic cells and tissue, will…
Read More » -
Biologics
AlloSource Partners In Manufacturing USA Institute
CENTENNIAL, Colo., June 18, 2019 /PRNewswire/ — AlloSource®, an organization dedicated to advancing the science and use of transplantable allogeneic cells and tissue, today…
Read More » -
Sports Medicine
AlloSource Awards Dr. Matthew Provencher The Annual Dr. Steven Gitelis Inspiration Award
CENTENNIAL, Colo., May 8, 2019 /PRNewswire/ — AlloSource®, an organization dedicated to advancing the science and use of transplantable allogeneic cells and…
Read More » -
Biologics
AlloSource Announces First Patient Enrolled In ProChondrix CR Cartilage Defect Study
CENTENNIAL, Colo., March 20, 2019 /PRNewswire/ — AlloSource®, an organization dedicated to advancing the science and use of transplantable allogeneic cells and tissue,…
Read More » -
Biologics
AlloSource Announces Two-Year Shelf Life On ProChondrix CR Fresh Cryopreserved Osteochondral Allograft
CENTENNIAL, Colo., March 12, 2019 /PRNewswire/ — AlloSource®, an organization dedicated to advancing the science and use of transplantable allogeneic cells and…
Read More » -
Biologics
AlloSource Granted Patent For Proprietary Laser Cutting Enclosure
CENTENNIAL, Colo., Nov. 16, 2018 /PRNewswire/ — AlloSource, an organization dedicated to advancing the science and use of transplantable allogeneic cells and tissue,…
Read More » -
Biologics
AlloSource Announces Two Presentations At The North American Spine Society Annual Meeting
CENTENNIAL, Colo., Sept. 25, 2018 /PRNewswire/ — AlloSource, an organization dedicated to advancing the science and use of transplantable allogeneic cells and tissue,…
Read More » -
Biologics
AlloSource Awards Dr. Kevin Shea The Annual Dr. Steven Gitelis Inspiration Award
CENTENNIAL, Colo., July 17, 2018 /PRNewswire-USNewswire/ — AlloSource, one of the largest nonprofit cellular and tissue networks in the country, offering life-saving and…
Read More » -
Biologics
AlloSource Announces Two Presentations On ProChondrix At The International Cartilage Repair Society World Congress
CENTENNIAL, Colo., April 10, 2018 /PRNewswire-USNewswire/ — AlloSource, an organization dedicated to advancing the science and use of transplantable allogeneic cells and tissue,…
Read More » -
Biologics
AlloSource and Stryker Launch ProChondrix CR Cryopreserved Osteochondral Allograft
CENTENNIAL, Colo., April 4, 2018 /PRNewswire-USNewswire/ — AlloSource and Stryker today announced the launch of ProChondrix® CR, a cryopreserved osteochondral allograft. ProChondrix CR is a…
Read More » -
Biologics
AlloSource Announces Raime Leeby Muhle As Chief Financial Officer
CENTENNIAL, Colo., Dec. 14, 2017 /PRNewswire-USNewswire/ — AlloSource, one of the nation’s largest providers of cartilage, bone, skin, soft-tissue and cellular allografts…
Read More » -
Biologics
AlloSource Announces Bob Lay As Chief Operating Officer
CENTENNIAL, Colo., Nov. 7, 2017 /PRNewswire-USNewswire/ — AlloSource, one of the nation’s largest providers of cartilage, bone, skin, soft-tissue and cellular allografts for…
Read More »